Systemic Levamisole-Induced Vasculitis in a Cocaine User without Cutaneous Findings: A Consideration in Diagnosis
- PMID: 26635879
- PMCID: PMC4618334
- DOI: 10.1155/2015/547023
Systemic Levamisole-Induced Vasculitis in a Cocaine User without Cutaneous Findings: A Consideration in Diagnosis
Abstract
Levamisole is a known immunomodulating agent frequently used as a cutting agent in cocaine consumed in the United States today. Numerous cases of anti-neutrophil cytoplasmic antibody (ANCA) vasculitis connected with the use of levamisole-adulterated cocaine have previously been reported in the literature, classically characterized by a retiform purpuric rash. We report a case of a crack-cocaine user without cutaneous abnormalities who developed ANCA-associated glomerulonephritis that progressed to renal failure. This case demonstrates the difficulties in solidifying the diagnosis of levamisole-induced vasculitis in the absence of cutaneous findings and the need to pursue more testing to establish causality in ANCA-associated vasculitis that has potential for severe end-organ damage in patients who continue to use cocaine.
Figures
References
-
- Pearson T., Bremmer M., Cohen J., Driscoll M. Vasculopathy related to cocaine adulterated with levamisole: a review of the literature. Dermatology Online Journal. 2014;18(7, article 1) http://escholarship.org/uc/item/6g18r9cv. - PubMed
-
- Geller L., Whang T., Mercer S., Phelps R. Retiform purpura: a new stigmata of illicit drug use? Dermatology Online Journal. 2011;17(2, article 7) - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
